Table 2.
Comparison of baseline information between patients in CAVD and control groups.
| Item |
Calcification group
N = 111 |
Control group
N = 201 |
Test value ( t/t′/X2) | p |
|---|---|---|---|---|
| Male (n, %) | (70, 63.1%) | (109, 54.2%) | 2.282 | 0.131 |
| Smoking (n, %) | (44, 39.6%) | (88, 43.8%) | 0.502 | 0.478 |
| Drinking (n, %) | (21, 18.9%) | (33, 16.4%) | 0.313 | 0.576 |
| Hypertensive (n, %) | (76, 68.5%) | (125, 62.2%) | 1.230 | 0.267 |
| Diabetes (n, %) | (49, 44.1%) | (48, 24.0%)∗∗∗ | 13.497 | < 0.001 |
| Coronary heart disease (n, %) | (67, 60.4%) | (100, 49.8%) | 3.236 | 0.072 |
| Age (year) | 68.09 ± 9.20 | 60.97 ± 11.06∗∗∗ | −5.773 | < 0.001 |
| Height (m) | 1.66 ± 0.13 | 1.67 ± 0.08 | 0.414 | 0.679 |
| Weight (kg) | 72.04 ± 13.97 | 73.23 ± 13.41 | 0.741 | 0.459 |
| BMI (kg/m2) | 27.03 ± 14.04 | 26.27 ± 3.83 | −0.718 | 0.473 |
| BSA (m2) | 1.78 ± 0.22 | 1.80 ± 0.21 | 0.735 | 0.463 |
| SBP (mmHg) | 136.69 ± 20.05 | 138.55 ± 18.64 | 0.819 | 0.414 |
| DBP (mmHg) | 81.59 ± 12.47 | 86.68 ± 11.73∗∗∗ | 3.591 | < 0.001 |
Abbreviations: BMI, body mass index; BSA, body surface area; DBP, diastolic blood pressure; SBP, systolic blood pressure.
∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001: statistically significant difference.